Lampera, Baby Girl .

HRN: 22-56-45  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/23/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
02/23/2023
03/01/2023
IVTT
16.8mg
Q24h
NEONATAL SEPSIS
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Bloodstream    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: